Journal
Frontiers in Pharmacology
Publication Date
1-1-2021
Volume
12
First Page
685092
Document Type
Open Access Publication
DOI
10.3389/fphar.2021.685092
Rights and Permissions
Shi S, Zhao Q, Ke C, Long S, Zhang F, Zhang X, Li Y, Liu X, Hu H and Yin S (2021) Loureirin B Exerts its Immunosuppressive Effects by Inhibiting STIM1/Orai1 and KV1.3 Channels. Front. Pharmacol. 12:685092. doi: 10.3389/fphar.2021.685092 © 2021 Shi, Zhao, Ke, Long, Zhang, Zhang, Li, Liu, Hu and Yin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Shi, Shujuan; Zhao, Qianru; Ke, Caihua; Long, Siru; Zhang, Feng; Zhang, Xu; Li, Yi; Liu, Xinqiao; Hu, Hongzhen; and Yin, Shijin, "Loureirin B exerts its immunosuppressive effects by inhibiting STIM1/Orai1 and K V 1.3 channels." Frontiers in Pharmacology. 12, 685092 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10514
Supplementary Material
